Operator of a medical platform intended to personalize depression treatment for every individual. The company's platform leverages biological, medical, and genetic data and innovative technology to predict the optimal drug treatment, and helps pharma companies differentiate product offerings and de-risk clinical trials by identifying responders and stratifying patients, and transforming care for psychiatric and neurological diseases by combining stem-cell technology, genomics, and artificial intelligence for treatment optimization and effective drug development, enabling patients to get access to fast treatment with few side effects and low dosing.